Filters

Meglumine adenosine cyclophosphate manufacturers

Filters

None products found

meglumine adenosine cyclophosphate

Injection, lyophilized 30 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #13622

This pharmaceutical company is a modern enterprise with over 50 years of experience. It boasts three factory sites spanning over one million square meters, housing over 30 workshops dedicated to producing a wide range of products. Their offerings include prescription medications like injectables (both lyophilized and small volume), traditional Asian medicine preparations, tablets, capsules, granules, suppositories, mixtures, and active pharmaceutical ingredients (APIs). The company prioritizes quality, holding cGMP certifications across all its workshops, along with ISO system certificates and PIC/S GMP accreditation. They serve both domestic and international markets, with a strong presence in over 60 countries across Africa, Asia, South America, and other regions. While specific therapy areas aren't mentioned, their diverse product portfolio suggests a focus on various healthcare needs.

Manufacturer usually replies in 22 days

meglumine adenosine cyclophosphate

Solution for injection 30 mg/2 ml, 60 mg/5 ml, 150 mg/10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #13622

This pharmaceutical company is a modern enterprise with over 50 years of experience. It boasts three factory sites spanning over one million square meters, housing over 30 workshops dedicated to producing a wide range of products. Their offerings include prescription medications like injectables (both lyophilized and small volume), traditional Asian medicine preparations, tablets, capsules, granules, suppositories, mixtures, and active pharmaceutical ingredients (APIs). The company prioritizes quality, holding cGMP certifications across all its workshops, along with ISO system certificates and PIC/S GMP accreditation. They serve both domestic and international markets, with a strong presence in over 60 countries across Africa, Asia, South America, and other regions. While specific therapy areas aren't mentioned, their diverse product portfolio suggests a focus on various healthcare needs.

Manufacturer usually replies in 22 days

meglumine adenosine cyclophosphate

Solution for injection 30 mg/2 ml, 60 mg/2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #9692
This pharmaceutical company focuses on developing and manufacturing innovative medicines across a range of therapeutic areas, including cardiovascular diseases, oncology, and nephrology. They have established core competencies in research & development, production, and sales, particularly for "four high and one anti-resistance" conditions (high blood sugar, hypertension, hyperlipidemia, high uric acid, and anti-tumor). Their product portfolio encompasses prescription medications, likely including insulin injections for diabetes treatment. They hold GMP certifications and product patents, signifying their commitment to quality and innovation. The company operates in key regions like North America and the EU, actively pursuing global commercialization and localization of its products.

Manufacturer usually replies in 76 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.